日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction to: Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study

更正:吉西他滨联合白蛋白紫杉醇或吉西他滨单药治疗FOLFIRINOX方案失败的转移性胰腺腺癌患者:一项真实世界的AGEO研究

Zaibet, Sonia; Hautefeuille, Vincent; Auclin, Edouard; Lièvre, Astrid; Tougeron, David; Sarabi, Mathieu; Gilabert, Marine; Wasselin, Julie; Edeline, Julien; Artru, Pascal; Bechade, Dominique; Morin, Clémence; Ducoulombier, Agnes; Taieb, Julien; Pernot, Simon

Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study

吉西他滨联合白蛋白紫杉醇或单用吉西他滨治疗FOLFIRINOX方案失败的转移性胰腺腺癌患者:一项真实世界的AGEO研究

Zaibet, Sonia; Hautefeuille, Vincent; Auclin, Edouard; Lièvre, Astrid; Tougeron, David; Sarabi, Mathieu; Gilabert, Marine; Wasselin, Julie; Edeline, Julien; Artru, Pascal; Bechade, Dominique; Morin, Clémence; Ducoulombier, Agnes; Taieb, Julien; Pernot, Simon